Press Releases from P&S Market Research - Pharmaceuticals (132 total)
Paroxysmal Nocturnal Hemoglobinuria Therapeutic Pipeline Analysis, 2017 Clinical …
Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare life-threatening disease characterized by destruction of red blood cells, blood clots, and compromised bone marrow function. Some of the symptoms of the disease include abdominal and back pain, dark urine, easy bruising or bleeding, fatigue or weakness, headache and shortness of breath. The risk factors for PNH include age, obesity and hormone therapy. According to the Johns Hopkins Medicine, approximately, one to one…
Cataract Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Colla …
Cataract is the clouding of eye lens and it can occur in either one or both the eyes. Cataract is generally more common among people over 80 years of age. According to the National Eye Institute, more than half of the Americans suffer from cataract. Eye lens is transparent and light sensitive and is located at the back of the eye. It helps to focus light rays on retina which…
Ankylosing Spondylitis Therapeutics Pipeline Analysis, 2017 by P&S Market Resear …
Ankylosing spondylitis is an idiopathic disease, associated with HLA-B27, IL23R and ERAP1 genes. Usually, fewer people get affected with ankylosing spondylitis irrespective of activation of genes. Blood test, X-ray test, Magnetic Resonance Imaging (MRI) and physical investigations are some of the ways to effectively diagnose the disease. The disease begins with the inflammation in joints in the vertebrae and pelvic bones and spine. The environmental factors are believed to be…
Diabetic Foot Ulcers Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Re …
Neuropathy, ischemia (peripheral vascular disease) and foot infection are some of the characteristic features of diabetic foot. According to the International Journal of Diabetes in Developing Countries, around 15% of all diabetic individuals are at high risk of developing diabetic foot ulcers. Barefoot walking, late presentation by patients, and belief in alternative system of medicines are contributing factors to the increasing prevalence of diabetic foot ulcers. Considerable growth in therapeutic…
Hemophilia Exhibits Emerging Pipeline with 53 Drug Candidates
The study analysed that the hemophilia pipeline comprises of 53 drug candidates, of which one drug candidate has been filed by LFB SA as biologics license application, four drug candidates are in Phase III stage, four drug candidates are in Phase II stage, 11 drug candidates are in Phase I stage, 27 drug candidates are in the Pre-Clinical stage and six drug candidates are in the Discovery stage of development.…
Hepatic Encephalopathy Therapeutics Pipeline Analysis, 2017 - Clinical Trials & …
Due to various risk factors the prevalence of hepatic encephalopathy has been increasing globally. The risk factors for the disease include the consumption of alcohol, drugs addiction for sedatives such as benzodiazepines; often used in treatment of anxiety disorders that can suppress the alcohol withdrawal, challenges in the correct diagnosis and other infections, such as jaundice and deficiency of liver enzymes. According to the Journal of Gastrointestinal & Digestive System,…
Nephrotic Syndrome Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Resu …
The growth in the pipeline of nephrotic syndrome is attributed to the increase in prevalence of individuals affected with diabetes, hypertension and hyperlipidaemia. Unhealthy lifestyle and unhygienic crops and fruits are also the factors that are contributing to the growth of therapeutic pipeline of nephrotic syndrome. Environmental factors are also thought to be responsible for occurrence of nephrotic syndrome. Funds from various organizations are contributing to the research and developments…
Narcolepsy Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Pat …
Narcolepsy is a disease that causes prolongation of extreme daytime sleepiness which can leads to muscle weakness and trouble sleeping at night. The complication associated with the disease are cataplexy, hallucinations and sleep paralysis. Due to these complication, the person is at increased risk of developing mental disorders such as schizophrenia. The environmental factors such as toxins that contains heavy metals, pesticides and weed killers and environmental tobacco smoke are…
Lennox-Gastaut Syndrome Therapeutics Pipeline Analysis, 2017 - Clinical Trials & …
Lennox-Gastaut Syndrome is a rare form of epilepsy that occurs in childhood and is characterized by seizures and intellectual disability. Adverse conditions such as injury to brain and its malformation, lack of oxygen to the new-born infants, infections of central nervous system and inherited metabolic or degenerative disorders are responsible for occurrence of Lennox-Gastaut Syndrome. Anti-epileptic medications are the main treatment option for Lennox-Gastaut Syndrome. The medication is often complicated…
Mucopolysaccharidosis (Morquio Syndrome) Therapeutics Pipeline Analysis, 2017 - …
Mucopolysaccharidosis (Morquio Syndrome), is a group of inherited disorder in which body becomes unable to breakdown the mucopolysaccharides. Accumulation of mucopolysaccharides in cells as well as connective tissues causes the malfunctioning of metabolic enzymes. This malfunctioning may lead to occurrence of variety of health problems. Mucopolysaccharidosis is autosomal dominant in most cases involving X-linked pattern of inheritance. The signs and symptoms of the disease varies by the type of…
Oral Mucositis Therapeutics Pipeline to Witness Many Technological Advancements …
The study analyzed that the oral mucositis therapeutics pipeline comprises approximately 18 drug candidates, of which one drug candidate is in Phase III stage of development, while seven drug candidates are in Phase II stage, four drug candidates are in Phase I stage, five drug candidates are in Pre-Clinical stage and one drug candidate is in the Discovery stage. Oral mucositis is the most common complication of chemotherapy in cancer…
Multiple Sclerosis Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Resu …
Multiple sclerosis therapeutic pipeline is expected to grow in future on account of increasing demands of drugs which can completely overcome the rising prevalence of the disease. Currently, multiple sclerosis is mainly impacting regions North America and Europe, some of the other geographies impacted with the disease include Eastern Asia and Sub-Saharan Africa, at very low rate. Major factors driving the growth of pipeline for multiple sclerosis are increasing incidences…
Polycystic kidney disease Therapeutics Pipeline Analysis, 2017 - Clinical Trials …
The platform of new drugs for the polycystic kidney disease is increasing on account of less number of drugs available for treatment of the disease. Polycystic kidney disease is a form of rare disease and the drugs which are available for treatment, have an adverse effect on the health of patients. Currently, the prevalence of polycystic kidney disease in the U.S. ranges from 1 in 400 to 1 in 1000…
Age-related Macular Degeneration Exhibits Emerging Pipeline with 55 Drug Candida …
The study analysed that the Age-related related macular degeneration therapeutics pipeline comprises of approximately 55 drug candidates, of which five drug candidates are in the Phase III stage, 12 drug candidates are in Phase II stage, 11 drug candidates are in Phase I, 24 drug candidates are in Pre-clinical stage, and there are three drug candidates which are in Discovery stage. Age-related macular degeneration is a disorder that causes loss…
The Pipeline of Drugs for Treating Candidiasis is Anticipated to Boost in Future
The study analyzed that the candidiasis therapeutics pipeline comprises approximately 22 drug candidates, of which two drug candidates are in Phase III stage of development, while five drug candidates are in Phase II stage, one drug candidate is in Phase I stage, 10 drug candidates are in Pre-Clinical stage and four drug candidates are in the Discovery stage. Candidiasis is a common type of fungal infection caused by fungus known…
Various Targets for the Disease Treatment Drives the Growth of Uveitis Therapeut …
The study analyzed that the uveitis therapeutics pipeline comprises 33 drug candidates, of which five drug candidates are in Phase III stage of development, seven drug candidates are in Phase II stage, three drug candidates are in Phase I, 15 drug candidates are in Pre-Clinical stage and three drug candidates are in Discovery stage. Uveitis is a type of inflammatory disease that causes swelling and destroys eye tissues. Occurrence of…
Synovial Sarcoma Exhibits Emerging Pipeline with 22 Drug Candidates
The study analysed that the Synovial sarcoma pipeline comprises of 22 drug candidates, of which one drug candidate is in Phase III stage, nine drug candidates are in Phase II stage, four drug candidates are in Phase I stage, four drug candidates are in Pre-Clinical stage and four candidates are in Inactive stage. Synovial sarcoma is rare type of cancer and approximately one to three people in one million people…
Various Targets for the Disease Treatment Drives the Candidiasis Therapeutics Pi …
According to a new research report “Candidiasis Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments” published by P&S Market Research, Candidiasis currently exhibits a pipeline with 22 drug candidates.
Browse Report Description at: www.psmarketresearch.com/market-analysis/candidiasis-therapeutics-pipeline-analysis
Candidiasis therapeutics pipeline in 2017
The study analyzed that the candidiasis therapeutics pipeline comprises approximately 22 drug candidates, of which two drug candidates are in Phase III stage of development, while five…
Nasopharyngeal Cancer Therapeutics Pipeline Analysis, 2017 - Clinical Trials & R …
Nasopharyngeal cancer therapeutic pipeline analysis is likely to grow mainly due to the rising prevalence of nasopharyngeal cancer, globally. Some of the main factors driving the pipeline analysis for nasopharyngeal cancer includes increasing geriatric population, rising tobacco and alcohol consumption and increasing prevalence of nasopharyngeal cancer, untapped market as being a rare form of head and neck cancer and increasing health awareness. According to American Cancer Society, the nasopharyngeal cancer…
Chronic Heart Failure Therapeutics Pipeline Analysis, 2017 - Clinical Trials & R …
Chronic heart failure therapeutic pipeline will increase in near future due to increasing cases of the disease. The prevalence of chronic heart failure is increasing globally due to the factors including obesity, diabetes, high blood pressure, cholesterol, less physical activity and tobacco consumption. These factors are contributing in driving the pipeline analysis for chronic heart failure. According to Centers for Disease Control and Prevention, around 5.7 million adults in the…
Asthma Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, …
The pipeline for asthma therapeutics is expected to experience a positive trend in the future, the increase is mainly attributable to decreasing air quality. The prevalence of asthma is increasing globally due to the factors including environmental factors, genetic factors, air pollution, less physical activity and smoking. These factors contribute immensely in driving the pipeline analysis for asthma. According to World Health Organization, around 235 million people suffered from asthma,…
Cluster Headache Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Result …
Rapidly increasing pace of life, change in lifestyle, higher stress levels, etc., are few of the major factors to which the increasing prevalence of cluster headache scan be attributed. Further, unhealthy dietary intake, smoking, alcoholconsumption and growing levels of pollutionare few other factors which are expected to fuel the incidence of cluster headache problem. The Therapeutic pipeline of cluster headache is expected to grow in future with the participation of…
Congestive Heart Failure Therapeutics Pipeline Analysis, 2017 - Patent, Designat …
Prevalence of congestive heart failure is witnessed to have increased, especially in Asia-Pacific and American region, due to rapid change in lifestyle of people, which in turn is results in various lifestyle diseases such as diabetes and high blood pressure. Additionally, other factors such as, sedentary nature of job, high cholesterol diet intake, lack of exercise, pollution, are also contributing to the increasing incidence of congestive heart failure, across the…
Diabetic Macular Edema Therapeutics Pipeline Analysis, 2017 - Clinical Trials & …
As estimated worldwide in 2011, the number of peoples with diabetes were around 346 million and its number is unceasingly getting bigger. It is expected to be double in number by 2030. Diabetic retinopathy and diabetic macular edema is occurring, which leads to the vision loss. These adverse conditions mostly occur in patient having high blood sugar level and high blood pressure. Therefore, the consequential increase in growth of diabetic…
Combination Therapies for the Disease Treatment Drives the Chronic Obstructive P …
The study analyzed that the chronic obstructive pulmonary disease pipeline comprises 65 drug candidates, of which eight drug candidates are in Phase III stage of development, 24 drug candidates are in Phase II stage, nine drug candidates are in Phase I, 22 drug candidates are in Pre-Clinical stage and two drug candidates are in Discovery stage. Chronic obstructive pulmonary disease is a broad term used for progression of various other…
Herpes simplex virus infections Exhibits Emerging Pipeline with 20 Drug Candidat …
The study analysed that the Herpes simplex virus infections pipeline comprises of 20 drug candidates, of which one drug candidate is in Phase III stage, five drug candidates are in Phase II stage, three drug candidates are in Phase I stage, eight drug candidates are in Pre-Clinical stage, three candidates are in discovery Phase. Herpes is an infection caused by a virus known as, herpes simplex virus. It is estimated…
Amyotrophic Lateral Sclerosis Exhibits Emerging Pipeline with 60+ Drug Candidate …
The study analysed that the Amyotrophic lateral sclerosis pipeline comprises of 69 drug candidates, of which one drug candidate is in Phase III stage, 16 drug candidates are in Phase II stage, nine drug candidates are in Phase I stage, 32 drug candidates are in Pre-Clinical stage, five candidates are inactive and six drug candidates are in discontinued stage. Amyotrophic lateral sclerosis is a neurodegenerative disorder in brain and spinal…
Insomnia Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Paten …
Insomnia therapeutic pipeline analysis is expected to experience vast growth in future, with the increasing level of stress being the major contributor for the rising prevalence of the disease. Some of the other major factors driving the pipeline for insomnia include lifestyle diseases, smoking, alcohol and tobacco consumption and increasing health awareness. According to the data by American Academy of Sleep Medicine, every year eight million people suffer from insomnia…
Glioma Therapeutics Pipeline Analysis, 2017 - Designation, Collaboration, and Ot …
The pipeline for glioma therapeutics is expected to experience rising research activities in future due to raise in funding by the orphan disease organization such as, National Organization of Rare Disorders. Many novel therapies such as, gene therapies, cell therapies are being developed for the treatment of glioma. Various technological advancements in research and development techniques is also be one of the key factors leading to the upsurge in the…
Acute coronary syndrome Therapeutics Pipeline Analysis, 2017 - Clinical Trials & …
The Acute coronary syndrome pipeline therapeutics pipeline is expected to increase on account of increasing population, which are at risk of severe cardiovascular disease. High blood pressure, uncontrollable blood sugar level, hypercholesterolemia, smoking are the main causes of developing acute coronary syndrome. Sometimes, stroke, emotional trauma also make a platform for emerging abnormalities in cardiovascular system. Amendments in lifestyle, routine and habit makes a big difference for increasing continuum of…
Gastrointestinal Stromal Tumor (GIST) Pipeline Analysis, 2017 - Clinical Trials …
The gastrointestinal stromal tumor (GIST) pipeline will rise with various collaborations and R&D investments. Hereditary risk and genetic factors play an important role in the development of gastrointestinal stromal tumor. Increasing family history of the disease and genetic factors associated with gastrointestinal stromal tumor and low penetration in the market are contributing towards the development of the pipeline. Additionally, increasing awareness regarding various health issues among people is another major…
Graves Disease Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, …
Graves disease therapeutic pipeline analysis is expected to increase owing to the high prevalence of the disease. Growing number of cases for hyperthyroidism is a major factor driving the pipeline analysis for Graves disease . In addition, increasing awareness regarding health issues among people is another major factor contributing towards the pipeline for Graves disease. According to American Thyroid Association, the prevalence of Graves disease has increased with increasing hyperthyroidism…
Candidiasis Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Co …
Candidiasis therapeutic pipeline is expected to witness increase in coming years due to rising prevalence of the disease resulting from use of corticosteroid medications, pregnancy, long-term use of broad-spectrum antibiotics and increasing health awareness. According to the data by Centers for Disease Control and Prevention, around 46,000 new cases of candidiasis occur every year in the U.S. Also, nearly 75% of all adult women have had at least one "yeast…
Juvenile idiopathic arthritis Therapeutics Pipeline Analysis, 2017 - Clinical Tr …
The expanding pipeline for juvenile idiopathic arthritis can be attributed to the increase in its prevalence. One of the major factor that stimulate the growth of pipeline and research is that the cause of juvenile idiopathic arthritis is not known. The juvenile idiopathic arthritis occurs mostly in children before 16 years of age. Since the disease occurs only in children, so the safety and efficacy concerns of the drugs is…
Psoriatic arthritis Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Res …
The number of drug candidates in pipeline for psoriatic arthritis are expected to increase on account of increase in the prevalence of psoriasis, globally. Psoriasis is the skin disease which is more common in Caucasian as compared to the African American and Asian Americans. The disease is symptomatized by white and scaly red patches. The prevalence of psoriatic arthritis has been increasing mainly in the patients, who are more susceptible…
Cushing's Syndrome Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Resu …
The expending growth of pipeline for Cushing’s syndrome therapeutics is attributed to the increase in prevalence of inflammatory disorders. For the treatment of various inflammatory disorders patients use corticosteroids, the long-term use of corticosteroids can lead to Cushing’s syndrome. In many diseases such as asthma and rheumatoid arthritis, corticosteroids are being used, for a lifelong period but at low doses. However, when the disease fails to respond to lower doses…
Chronic Kidney Disease Therapeutics Pipeline Analysis, 2017 - Clinical Trials & …
The therapeutics pipeline of chronic kidney disease has been increasing on account of rising prevalence of diabetes and high blood pressure in patients. The diabetes and blood pressure are the main causes of chronic kidney disease, which is also related to cardiovascular disease. Due to altered lifestyle, the chances of incidence of high blood pressure and diabetes is on a rise. Currently, the prevalence of chronic kidney disease is around…
Hereditary angioedema Therapeutics Pipeline Analysis, 2017 - Patent, Designation …
The pipeline of hereditary angioedema is increasing on account of rising instances of angioedema, globally. Currently, an estimated prevalence of hereditary angioedema in the world is 1 in 10,000 to 1 in 150,000. Major factors driving the growth of pipeline for hereditary angioedema include increasing prevalence of attacks of angioedema and rising cases of angioedema in association with other conditions like significant hypotension resulting from abdominal attacks, low market penetration…
Global Biosimilars Market Size, Share, Development, Growth and Demand Forecast t …
Market Overview
Biosimilars are complex biological products made from living organism that include microorganisms such as bacteria and yeast, humans, and animals. These biological products are similar biological product also known as biological reference product, that have been approved by the U.S. Food Drug and Administration (USFDA). Biosimilars are compared with the biological reference products and licensed by the USFDA. Patent expiration of biological reference product is the key factor leading…
Hereditary angioedema Therapeutics Pipeline Analysis, 2017 - Clinical Trials & R …
The pipeline of hereditary angioedema is increasing on account of rising instances of angioedema, globally. Currently, an estimated prevalence of hereditary angioedema in the world is 1 in 10,000 to 1 in 150,000. Major factors driving the growth of pipeline for hereditary angioedema include increasing prevalence of attacks of angioedema and rising cases of angioedema in association with other conditions like significant hypotension resulting from abdominal attacks, low market penetration…
Peripheral Arterial Disease Therapeutics Pipeline Analysis, 2017 - Patent, Desig …
On account of increasing number of cases related to high blood pressure and diabetes, growth in pipeline of peripheral arterial disease is anticipated in the next few years. One of the main causes of peripheral arterial disease is smoking, which leads to the building up of plaque inside the arteries that carry oxygen rich blood. As per the data provided by World Health Organization in 2015, nearly 1.1 billion people…
Myasthenia Gravis Therapeutics Pipeline Analysis 2017 - Clinical Trials & Result …
Myasthenia gravis is a neuromuscular disease that leads to varying degrees of skeletal muscle weakness. It is an autoimmune disease resulting from the antibodies blocking or destroying nicotinic acetylcholine receptors at the junction between the nerve and muscle, thus preventing nerve impulses rom triggering muscle contractions. Growth is anticipated in the myasthenia gravis therapeutics pipeline on account of increasing participation of organizations, such as National Organization for Rare Disorder, that…
Dry Eye Disease Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results …
Growth in the pipeline of dry eye disease therapeutics is anticipated over next few years on account of increasing incidences of people being diagnosed with diabetes and deficiency of vitamins such as A and B, which is majorly caused due to change in dietary intake and unhealthy lifestyle. This in turn leads to increase in risk of ocular infections and other bothersome symptoms such as visual disturbance, ocular discomfort and…
Fabry Disease Therapeutics Pipeline Analysis, 2017 - Patent, Designation, Collab …
Fabry disease is a type of inherited genetic disease caused due to abnormal deposition of a fatty substance, called globotriaosylcera-mide, in blood vessel walls throughout the body. This further leads to development of other complications, which result in severe morbidities and can also be fatal, in some cases. Anticipated growth of therapeutic pipeline of fabry disease can be attributed to the rareness of the disease, as it is usually found…
Small Lymphocytic Lymphoma Therapeutics Pipeline Analysis, 2017 - Clinical Trial …
The rising prevalence of small lymphocytic lymphoma is responsible for the upsurge in research and development of therapeutics that can control progression of the disease, and in turn lead to discovery of new targets that would assist in curing cancer. Increasing adoption of unhealthy lifestyle, unchecked use of pesticides in cultivating crops and fruits along with intake of unhygienic food items causes virus infection such as Hepatitis C and Epstein-Barr…
Ulcerative Colitis has a Promising Pipeline with approximately 89 Drug Candidate …
The ulcerative colitis pipeline analysis report covers approximately 89 drug candidates, of which 68 drug candidates are in active stage. Among the active drug candidates, one drug is in NDA filed stage, 11 are in Phase III stage, 28 are in Phase II stage, 13 are in Phase I stage, 14 are in Pre-Clinical stage and one drug is in Discovery stage of development. The development of 18 ulcerative colitis…
Cystic Fibrosis Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results …
Increasing prevalence of cystic fibrosis being witnessed mostly in Europe and the U.S. due to lack of awareness among people towards genetic diseases. In addition, some other factors contributing to the increasing occurrence of cystic fibrosis disease include smoking during pregnancy, hereditary disorder, and premature mortality of infants. The therapeutic pipeline of this particular disease is expected to grow in the future on account of major pharmaceutical companies betting involved…
Fragile-x Syndrome Therapeutics Pipeline Analysis, 2017 - Patent, Designation, C …
Due to lack of awareness among people regarding genetic disorders which leads to mutations in one’s DNA, the prevalence of fragile-x syndrome is increasing, across the globe. Smoking, alcohol consumption during pregnancy and hereditary disorders are few of the primary reasons to for the increase in prevalence of fragile-x syndrome. The therapeutic pipeline of fragile-x syndrome is expected to grow more rapidly in the future on account of active involvement…
Chronic Inflammatory Demyelinating Polyneuropathy Therapeutics Pipeline Analysis …
Chronic inflammatory demyelinating polyneuropathy pipeline is expected to grow in the next few years on account of increasing prevalence of the disease, which is noticed by progressive muscle weakness, loss of deep tendon reflexes, abnormal sensations, etc. According to a study conducted by American Association of Neuromuscular & Electrodiagnostic Medicine, around 40,000 people in the U.S. get affected from the disease, every year. High prevalence of chronic inflammatory demyelinating polyneuropathy…
Chronic Myelocytic Leukemia Therapeutics Pipeline Analysis, 2017 by P&S Market R …
Chronic myelocytic leukemia therapeutic pipeline analysis is expected to grow rapidly due to the increasing prevalence of the disease, globally. Some of the main factors driving the pipeline analysis for chronic myelocytic leukemia include increasing aging population and rising prevalence of chronic myelocytic leukemia, and increasing health awareness. Chronic myelocytic leukemia have high incidence rate in men and is the second most common type of cancer occurring in male adults.…
